Replies to post #54731 on Avid Bioservices Inc (CDMO)

[Thurly]

Moby, you've been successfully refuted on every point you've made now. The type of clinicaltrials.gov documents you cite as authoritative...

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52855529

...turn out in other instances to specify safety as a focus of trials but not specify the same in the Designated as Safety Issue section of the same document THREE TIMES for Bavituximab trials alone.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52902449

God only knows how many instances we'd find if we looked at the records for other clinical candidates.

The other document you cited, saying "Why not go directly to the source..."

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52862740

clearly states that safety is monitored throughout the clinical trial process.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52859452

That sent you suddenly away from "the source", circling back to your original argument re: the authority of the clinicaltrials.gov documents where you stated, Like it or not, the proof is the lack of safety in both the primary and secondary outcome measures in those 3 Peregrine phase II trials. Two of which are the "gold standards" that were approved by the FDA.

http://investorshub.advfn.com/boards/replies.aspx?msg=52863519
and
http://investorshub.advfn.com/boards/replies.aspx?msg=52883556

The flaw of which argument was clearly demonstrated by, again,

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=52902449

And round and round we go.

Anyway, good luck. I'm done.